Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Special gels help heal diabetic foot sores and reduce the risk of amputation or death.

Hydra can help understand human hair follicle microbiomes and develop new skin disease therapies.

A new mutation in the DCAF17 gene was found in a Chinese family, causing Woodhouse-Sakati syndrome and diabetes.

Some alternative treatments for vitiligo show promise but need more research to confirm their safety and effectiveness.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Machine learning is effective in predicting gene functions and their relationships with diseases.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair can be damaged by daily routines, but protein-based products can protect and improve it.

Eating isoflavone can help mice grow hair by increasing a growth factor.

Merino wool fibers change shape with moisture, while human hair shape stays the same.

The research found genes that may protect certain scalp cells from hair loss.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Alzheimer's patients have higher levels of certain chemicals in their hair.

Hair increases in size when it absorbs water, and treatments like bleaching affect how much water it can take in.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Different tiny organisms live in human hair follicles and can affect both health and skin conditions, including acne and hair loss.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.